time_published,title,sentiment_score,sentiment_label,ticker
2025-11-21 12:45:00,XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.,0.245009,Somewhat-Bullish,JNJ
2025-11-21 12:45:00,"XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - XOMA Royalty  ( NASDAQ:XOMA ) , LAVA Therapeutics  ( NASDAQ:LVTX ) ",0.229205,Somewhat-Bullish,JNJ
2025-11-21 12:13:00,Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?,0.241027,Somewhat-Bullish,JNJ
2025-11-20 18:10:00,Will Librexia ACS Study Setback Dent BMY's Cardiovascular Portfolio?,0.182955,Somewhat-Bullish,JNJ
2025-11-20 09:00:00,"Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi®  ( golimumab ) ",0.145956,Neutral,JNJ
2025-11-20 09:00:00,"Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi®  ( golimumab ) ",0.145929,Neutral,JNJ
2025-11-19 20:02:21,A Closer Look at Johnson & Johnson's Options Market Dynamics - Johnson & Johnson  ( NYSE:JNJ ) ,0.165996,Somewhat-Bullish,JNJ
2025-11-19 17:24:46,Why Johnson & Johnson's Share Price Is Popping This Month,0.01457,Neutral,JNJ
2025-11-19 15:52:00,Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study,0.206509,Somewhat-Bullish,JNJ
2025-11-19 14:45:00,Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B,0.126978,Neutral,JNJ
2025-11-19 14:45:00,"Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B - ALX Oncology Holdings  ( NASDAQ:ALXO ) , Erasca  ( NASDAQ:ERAS ) ",0.126887,Neutral,JNJ
2025-11-19 14:15:00,Don't Give Up on Dividend Stocks. 5 Dividend Kings Down Between 5% and 33% to Buy in November,0.264236,Somewhat-Bullish,JNJ
2025-11-19 14:00:05,Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,0.228402,Somewhat-Bullish,JNJ
2025-11-19 13:53:00,BAYRY Obtains Approval for Hormone Free VMS Treatment Lynkuet in the EU,0.231704,Somewhat-Bullish,JNJ
2025-11-19 03:45:00,Nailing Systems Market Set for Strong Growth as Demand Rises Across Orthopedic and Trauma Care Segments: Verified Market Research®,0.28448,Somewhat-Bullish,JNJ
2025-11-18 16:03:00,"J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B",0.045959,Neutral,JNJ
2025-11-18 14:37:00,Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3,0.247199,Somewhat-Bullish,JNJ
2025-11-18 13:43:00,Buy 3 Columbia Mutual Funds for Growth and Income,0.290969,Somewhat-Bullish,JNJ
2025-11-18 11:45:00,2 No-Brainer Healthcare Stocks to Buy Now,0.139421,Neutral,JNJ
2025-11-18 09:27:00,"The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum",0.298053,Somewhat-Bullish,JNJ
2025-11-18 06:01:00,Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer,0.192932,Somewhat-Bullish,JNJ
2025-11-18 06:01:00,Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer - Zymeworks  ( NASDAQ:ZYME ) ,0.188115,Somewhat-Bullish,JNJ
2025-11-17 18:45:00,Consumer Brands Shake Things Up...With Mergers,0.0971,Neutral,JNJ
2025-11-17 17:23:38,Johnson & Johnson Adds Prostate Cancer Candidate In Around $3 B Halda Deal - Johnson & Johnson  ( NYSE:JNJ ) ,0.048963,Neutral,JNJ
2025-11-17 16:26:43,Court Rejects Bid To Block Kenvue's $398 Million Shareholder Payout In Tylenol Safety Dispute - Kenvue  ( NYSE:KVUE ) ,-0.031909,Neutral,JNJ
2025-11-17 14:52:45,Nvidia and 19 Other Stocks Now Make Up 50% of the S&P 500. Here's What It Means for Your Investment Portfolio.,0.18357,Somewhat-Bullish,JNJ
2025-11-17 14:48:00,Top 3 MassMutual Mutual Funds Worth Noting,0.27447,Somewhat-Bullish,JNJ
2025-11-17 13:58:00,BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ,0.100112,Neutral,JNJ
2025-11-17 13:40:00,"Take the Zacks Approach to Beat the Markets: Macy's, United Natural Foods & Monster Beverage in Focus",0.194098,Somewhat-Bullish,JNJ
2025-11-17 13:15:00,Halda Therapeutics Announces Acquisition by Johnson & Johnson,0.063328,Neutral,JNJ
2025-11-17 12:08:00,Growth or Stability? A 2025 Investment Face-Off Between LLY and JNJ,0.319846,Somewhat-Bullish,JNJ
2025-11-16 22:47:04,The Vanguard Dividend Appreciation Index Fund ETF  ( VIG )  Delivers Stronger Growth Than the iShares Core High Dividend ETF  ( HDV ) ,0.235136,Somewhat-Bullish,JNJ
2025-11-16 18:11:23,The Schwab U.S. Dividend Equity ETF  ( SCHD )  Offers a Higher Yield and Lower Cost Than the iShares Core High Dividend ETF  ( HDV ) ,0.186464,Somewhat-Bullish,JNJ
2025-11-15 12:59:16,Jana Partners push to break up Cooper Cos. could change the stock's outlook,0.200367,Somewhat-Bullish,JNJ
2025-11-14 22:00:00,Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update,0.143431,Neutral,JNJ
2025-11-14 16:17:52,Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy - Bristol-Myers Squibb  ( NYSE:BMY ) ,-0.016748,Neutral,JNJ
2025-11-14 12:59:00,Pharma ETFs in Spotlight Following Robust Q3 Earnings Results,0.176987,Somewhat-Bullish,JNJ
2025-11-14 12:57:00,Top Robotics Stocks to Add to Your Portfolio for Impressive Returns,0.331089,Somewhat-Bullish,JNJ
2025-11-13 17:08:15,Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia - Legend Biotech  ( NASDAQ:LEGN ) ,0.23701,Somewhat-Bullish,JNJ
2025-11-13 17:08:00,Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia,0.250745,Somewhat-Bullish,JNJ
2025-11-13 17:00:33,A Look Into Johnson & Johnson Inc's Price Over Earnings - Johnson & Johnson  ( NYSE:JNJ ) ,0.054513,Neutral,JNJ
2025-11-13 16:30:04,Why Is Johnson & Johnson  ( JNJ )  Up 1.7% Since Last Earnings Report?,0.264864,Somewhat-Bullish,JNJ
2025-11-13 16:01:52,Decoding Johnson & Johnson's Options Activity: What's the Big Picture? - Johnson & Johnson  ( NYSE:JNJ ) ,0.228922,Somewhat-Bullish,JNJ
2025-11-13 13:45:00,Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger - Salarius Pharmaceuticals  ( NASDAQ:SLRX ) ,0.224637,Somewhat-Bullish,JNJ
2025-11-13 13:45:00,Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger,0.173775,Somewhat-Bullish,JNJ
2025-11-13 13:07:00,Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month,0.30221,Somewhat-Bullish,JNJ
2025-11-13 12:30:00,LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq,0.11922,Neutral,JNJ
2025-11-13 11:20:02,Should Invesco Dow Jones Industrial Average Dividend ETF  ( DJD )  Be on Your Investing Radar?,0.149579,Neutral,JNJ
2025-11-13 10:04:00,2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon,0.263687,Somewhat-Bullish,JNJ
2025-11-13 08:55:00,2 Strong Healthcare Stock Picks for Dividend Investors,0.321174,Somewhat-Bullish,JNJ
